Common combinations include the following
While treatment varies by severity, common approaches include: Dietary Modifications Small, frequent meals Low-fat, low-fiber diet Soft or liquid foods Avoid raw vegetables, fatty meats, and high-fiber grains Medications Prokinetics to improve stomach motility Anti-nausea medications Acid reduction therapies (if needed) Advanced Interventions Feeding tubes (severe cases) IV hydration Gastric electrical stimulation Surgery (rare) Important: Stopping the GLP-1 drug may improve symptoms but many patients continue to experience symptoms long-term
No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
The most frequently reported adverse events with combination therapy are gastrointestinal symptoms, including nausea, vomiting, and diarrhea, which are primarily attributable to GLP-1 receptor agonists and may occur more often than with SGLT2 inhibitor monotherapy [24, 43]
Alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage
Human islets were obtained from the Integrated islet Distribution Program